Roche: Matthew Sause

Oct 28, 2019

Roche Diagnostics has named Matthew Sause as president and CEO, North America, effective Nov. 4. He replaces Jack Phillips, who left Roche at the end of August. Sause was previously the senior VP and head of global commercial product strategy at Gilead Sciences. From 2002 to 2014, Sause worked in the diagnostics division at Roche, filling US-based sales roles in molecular diagnostics, commercial operations positions in Asia, and country leadership in Ireland. In 2014, Sause moved to the pharmaceuticals division, where he was president of country operations in Peru and South Korea, before becoming VP and lifecycle leader for Roche's cancer drug Tecentriq.

Roche: Matthew Sause

Personalis, Tempus Partner to Commercialize Blood-Based Minimal Residual Disease Test

Thermo Fisher Scientific, Pfizer Canada Grant C$300K to Study NGS in Colorectal Cancer Care

Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test

Fetal Exome Sequencing Studies Point to Noninvasive Prenatal Screening Applications

Quadram Institute Leads €1.1M Consortium Using Nanopore Sequencing for AMR Surveillance